EARLY DETECTION THROUGH LUNG CANCER SCREENINGS

TYPE: Late Breaking Abstract TOPIC: Lung Cancer PURPOSE: cancer is the second most diagnosed and leading cause of cancer-related deaths in United States. While early detection has a direct impact on survival outcomes, sadly 47% lung late stage (Stage III or IV)1. Reference: 1. https://www.lung.org/getmedia/381ca407-a4e9-4069-b24b-195811f29a00/solc-2020-report-final.pdf., American Association State 2020 Report. METHODS: McLeod Health implemented Healthy Lungs Initiative (HLI) FY2019 to include 3 modalities for management including screenings, incidental nodule findings, multidisciplinary conference diagnosis/treatment suspicious findings. Following USPSTF guidelines managed by an RN navigator, screening modality resulted early-stage diagnosis rate 81%, compared 23% nationally1. RESULTS: For FY2021: 1,220 patients received 164 results Lung-RADS score higher, 26 (2%) were with cancer, 21 (81%) cancers at (I, II) recommendations curative intent treatment, 4 (19%) later (III, IV). CONCLUSIONS: In concordance data, high-risk developing demonstrates rates earlier cancers, offering opportunities treatment increased survivability. CLINICAL IMPLICATIONS: The return investing human capital, processes tools support work realized both financial clinical outcomes. DISCLOSURE: No significant relationships. KEYWORD: